Thailand · Delayed Price · Currency is THB Mega Lifesciences PCL Earnings Call Transcripts
Fiscal Year 2025
-
FY 2025 saw revenue decline narrow to 7.8% YoY, with branded business growing 4.3% and distribution recovering in 2H. Gross margin improved, and EBITDA rose 2.6% YoY. FY 2026 revenue is guided to grow 8-12%, led by branded business and Myanmar recovery.
-
Nine-month 2025 revenue reached THB 10.4 billion, with branded business growing 4.3% YoY and distribution stabilizing. Q3 net profit rose 29.1% YoY, and the company expects low double-digit branded growth and stable dividends, while investing in new manufacturing facilities.
-
Strategic focus on brand and product development is supported by a five-year growth plan, with higher second-half revenue and stable profitability expected. CapEx is concentrated in Indonesia and Vietnam, and internal cash flow is projected to cover investments and debt.
-
Q1 2025 revenue fell 14.1% due to Myanmar distribution decline, but branded business grew 2.8% and gross margins improved. Strong performance in Africa and other markets, ongoing expansion in Indonesia and Vietnam, and a stable net cash position support a positive outlook despite Myanmar and tax headwinds.
-
Revenue and profits remained flat in 1H and 2Q 2024, with branded and Pharma businesses showing growth while distribution and consumer segments in Myanmar declined. Strategic expansion continues in Southeast Asia and Africa, with a robust product pipeline and focus on operational efficiency.
Fiscal Year 2024
-
Approval for a major Vietnam project reduces political risk, while focus shifts to monoclonal antibody and new product launches. Annual growth targets of 27–28% are set, with internal accruals expected to fund expansion.
-
Revenue and net profit were flat YoY in 1H24, with improved gross margins offset by higher SG&A. Branded business is growing, driven by pharma, while distribution faces headwinds in Myanmar. Outlook for 2024 is 5-6% growth, with potential for 8-10% in 2025, supported by new product launches.